Phase I/ II study of S-1 and cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer.
Phase 1
- Conditions
- ung cancer
- Registration Number
- JPRN-UMIN000005389
- Lead Sponsor
- ational Cancer Center Hospital East
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Not provided
Exclusion Criteria
Exclusion criteria were:active concomitant malignancy; active pulmonary fibrosis or interstitial pneumonia ; watery diarrhea; serious complications; pregnancy; psychotic disorder; and drug allergy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 2-year survival rate
- Secondary Outcome Measures
Name Time Method objective response rate,overall survival,progression-free survival,toxicity